[ORGANIZATION]
Atai Beckley
Featured in 2 tracked stories · first seen
Situations
Eli Lilly therapeutic pipeline expansion
2 clusters · 3 sources · last updated
Latest: Eli Lilly expands research in dermatology and psychedelics
Eli Lilly has been pursuing strategic expansions into new therapeutic fields, specifically mental health, immunology, and dermatology. In September 2026, the company completed its acquisition of AtaiBeckley, a biopharmac
Also covered in
-
SpaceX and psychedelic biotech sectors see significant investment interest
[BUSINESS] · 3 sources ·